药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Desmethylprodine
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Relugolix.
Desmethylprodine
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Relugolix.
Desmethylprodine
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Relugolix.
Desmethylprodine
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Relugolix.
Desmethylprodine
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Relugolix.
Desmethylprodine
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Relugolix.
Desmethylprodine
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Relugolix.
Desmethylprodine
Cariporide
The risk or severity of QTc prolongation can be increased when Cariporide is combined with Relugolix.
Desmethylprodine
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Relugolix.
Desmethylprodine
Vernakalant
The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Relugolix.
Desmethylprodine
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Relugolix.
Desmethylprodine
Methsuximide
The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Relugolix.
Desmethylprodine
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Relugolix.
Desmethylprodine
Celiprolol
The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Relugolix.
Desmethylprodine
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Relugolix.
Desmethylprodine
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Relugolix.
Desmethylprodine
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Relugolix.
Desmethylprodine
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Relugolix.
Desmethylprodine
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Relugolix.
Desmethylprodine
Terodiline
The risk or severity of QTc prolongation can be increased when Relugolix is combined with Terodiline.